Valaciclovir update.
Bell
A R
AR
Glaxo Wellcome Research and Development, Greenford, Middlesex, United Kingdom.
D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D006558:Herpes Genitalis / Q000188:drug therapy* / Q000517:prevention & control; D006562:Herpes Zoster / Q000188:drug therapy*; D006801:Humans; D011355:Prodrugs / Q000627:therapeutic use*; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000998:Antiviral Agents; D011355:Prodrugs; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir